| Trial ID: | L2011 |
| Source ID: | NCT01109927
|
| Associated Drug: |
Insulin
|
| Title: |
Early Insulin Treatment in Patients With Latent Autoimmune Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes, Autoimmune|Diabetes Mellitus, Adult-Onset
|
| Interventions: |
DRUG: Insulin
|
| Outcome Measures: |
Primary: Glucagon stimulated C-peptide, Glucagon stimulated C-peptide is measured at diagnosis and annually for three years. Basal values will be compared to values obtained after 36 months., 36 months after entering the study |
|
| Sponsor/Collaborators: |
Sponsor: Lund University Hospital | Collaborators: Landstinget Kronoberg, Sweden
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
42
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
1995-02
|
| Completion Date: |
2005-05
|
| Results First Posted: |
|
| Last Update Posted: |
2010-04-23
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01109927
|
